Waters (WAT) Climbed, But What Is Driving Attention Now?

Why Waters stock is back in focus

Waters (WAT) is back on investor radars after lifting its full-year 2026 earnings outlook, increasing expected revenue by US$43 million at the midpoint and leaning on what management calls new growth vectors.

Recent price action suggests investors are leaning into that story. The stock has climbed 4.17% on a 1-day share price return to US$476.70, helped by the guidance hike. A 24.80% year to date share price return and 26.59% 1-year total shareholder return point to building momentum around Waters despite mixed recent earnings headlines and the AI-Powered Peak Integration launch in late October.

Scan how other lab-tech and AI workflow stocks are priced relative to their momentum story by jumping into our curated list of 19 high quality undiscovered gems.

Bulls point to Waters’ raised 2026 guidance and AI push, while bears highlight a high 191.5x P/E and recent earnings pressure. Which side does the current valuation actually support?

Most Popular Narrative: 1% Overvalued

Waters is trading at $476.70 against an analyst consensus fair value of $470.82, which the analyst consensus Narrative on Simply Wall St treats as essentially fully priced based on detailed revenue and earnings forecasts discounted at 8.24%.

Recurring and application specific revenues continue to build, with chemistry columns growing 10% in Q2 2026, underlying chemistry growth at about 16% after timing effects and GLP 1 testing revenue up more than 40%. This points to a larger installed base and higher consumables pull through that can support revenue visibility and operating leverage.

See why 20 investors see Waters as 1% overvalued.

Result: Fair Value of $470.82 (ABOUT RIGHT)

Still, the Waters narrative could wobble if integration synergies with BD Biosciences disappoint, or if ongoing weakness in China continues to drag on the acquired units.

Find out about the key risks to this Waters narrative.

Next Steps

Mixed signals around Waters can feel noisy, so move quickly from headline takes to your own judgment by weighing its 1 key reward and 3 important warning signs.

Looking for more ideas beyond Waters?

If Waters has you thinking harder about where growth, balance sheet strength and income potential intersect, now is the moment to widen your opportunity set.

• Target potential mispriced opportunities and filter for quality by scanning our 33 high quality undervalued stocks.
• Prioritise resilience first and see which companies score well on risk by reviewing the 30 resilient stocks with low risk scores.
• Zero in on financial strength and fundamentals that can support staying power through cycles with the list of solid balance sheet and fundamentals (25 results).

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com